Orris

Kindly suggest me topic for thesis topic breast i am trainee Drnb surgical oncology

Reading File
Finding Sources
Searching PubMed

breast neoplasms AND surgery

Searching the Web

breast surgical oncology research priorities de-escalation surgery trial 2025 2026

For a DRNB Surgical Oncology thesis, choose a question that is clinically relevant, has sufficient patient numbers at your centre, and can be completed reliably within 12-24 months. A retrospective cohort study is often the most practical format.

Strong, feasible breast surgical oncology thesis topics

  1. Predictors of axillary pathological complete response after neoadjuvant systemic therapy in initially node-positive breast cancer
    • Compare clinicopathological and imaging predictors with final axillary pathology.
    • Relevant to targeted axillary dissection and avoiding unnecessary ALND.
  2. Accuracy and oncological outcomes of targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer
    • Outcomes: false-negative rate, identification rate, residual nodal disease, short-term axillary recurrence.
    • Very suitable if clipped-node localisation is performed at your unit.
  3. Breast-conserving surgery after neoadjuvant chemotherapy: re-excision rate, predictors of margin positivity, and local recurrence
    • Practical retrospective study with clear endpoints.
    • Can compare conventional localization with oncoplastic approaches if available.
  4. Oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: surgical margins, complications, re-excision, and patient-reported cosmetic outcomes
    • Good surgical thesis, but ensure adequate follow-up and a usable cosmetic/outcome assessment method.
  5. Discordance between clinical-radiological response and pathological response following neoadjuvant therapy in breast cancer
    • Examine ultrasound, mammography, MRI where available, versus surgical histopathology.
    • Can stratify by molecular subtype, especially HER2-positive and triple-negative disease.
  6. Role of sentinel lymph-node biopsy in ductal carcinoma in situ undergoing mastectomy: institutional outcomes and predictors of occult invasion
    • Highly feasible, particularly where DCIS cases are frequent.
    • Useful for evaluating selective axillary staging and avoiding overtreatment.
  7. Factors associated with delay from diagnosis to initiation of definitive treatment in breast cancer, and their relationship with stage and outcomes
    • A strong locally relevant topic in Indian settings.
    • Include patient, disease, referral, diagnostic, financial, and system-level factors.
  8. Impact of neoadjuvant chemotherapy completion and dose intensity on pathological complete response in triple-negative and HER2-positive breast cancer
    • Simple, clinically useful, and publishable if records are good.
    • pCR provides a meaningful primary endpoint.
  9. Patterns and predictors of locoregional recurrence after breast-conserving therapy
    • Evaluate tumor biology, margins, nodal status, systemic therapy, radiation completion, and follow-up.
    • Requires longer follow-up but can use an existing historical cohort.
  10. Real-world outcomes of breast cancer surgery in elderly patients: treatment selection, complications, and oncological outcomes
  • Especially useful if your centre sees a significant elderly population.
  • Can assess whether age, frailty, comorbidities, and biology influence surgical decision-making.

My top 3 recommendations

If your centre has a good neoadjuvant breast practice:
  1. “Predictors of axillary pathological complete response after neoadjuvant systemic therapy in biopsy-proven node-positive breast cancer: a retrospective cohort study.”
  2. “Breast-conserving surgery after neoadjuvant chemotherapy: predictors of margin positivity, re-excision, and early locoregional outcomes.”
  3. “Clinical, radiological, and pathological concordance of response to neoadjuvant systemic therapy in breast cancer.”
These are relevant to the present move toward appropriately reducing axillary and locoregional treatment without compromising cancer outcomes. Current breast-surgery discussions particularly focus on selecting patients for omission or reduction of sentinel-node and other locoregional interventions, as reflected in the ASBrS 2026 proceedings.

Best single topic for a DRNB thesis

“Predictors of axillary pathological complete response following neoadjuvant chemotherapy in initially node-positive breast cancer: a retrospective cohort study.”
Why this is a good choice:
  • Directly relevant to a surgical oncologist.
  • Clear primary endpoint: ypN0.
  • Feasible with routine data: age, subtype, clinical node burden, imaging response, chemotherapy, surgery, and pathology.
  • Can generate future institutional evidence for targeted axillary dissection or axillary de-escalation.
  • Likely publishable if the cohort is adequately sized.
Avoid an overly ambitious topic such as long-term survival after reconstruction or a randomized trial unless your department already has a research infrastructure and high case volume. Recent reviews still show active uncertainty in several surgical areas, including the benefit of breast surgery in metastatic disease, supporting carefully designed institutional outcome studies rather than assuming practice should change based on retrospective data alone (2025 Cochrane review, PMID: 41263247).

More topic and easy to do prospective

Reading File
Finding Sources
Searching PubMed

breast surgery AND patient reported outcomes

Searching the Web

prospective observational study breast surgery patient reported outcomes seroma drain surgical site infection 2025

For an easy prospective DRNB thesis, choose a prospective observational cohort with simple data collection, a short follow-up period of 30 days to 3 months, and no change in standard treatment. Avoid randomized trials unless your department has strong support.

Easy prospective breast surgical oncology topics

TopicDesign and follow-upWhy it is easy
1. Prospective assessment of postoperative seroma after modified radical mastectomy and its predictorsCohort, follow-up until drain removal and 30 daysCommon operation and outcome; simple daily drain-output chart
2. Factors predicting prolonged drain duration after modified radical mastectomyCohort, follow-up until drain removalClear objective endpoint, no special investigations needed
3. Incidence and predictors of surgical-site infection after breast cancer surgeryCohort, 30-day follow-upStandard definitions, clinically important, easy data collection
4. Acute postoperative pain and analgesic requirement after breast cancer surgeryProspective observational study, postoperative day 0-7 or 30 daysUse Numeric Rating Scale, record analgesic use
5. Incidence and risk factors for early upper-limb morbidity after axillary dissectionCohort, baseline and 1-month/3-month assessmentMeasure shoulder range of motion, pain, numbness, arm circumference
6. Early arm symptoms after sentinel lymph-node biopsy versus axillary lymph-node dissectionComparative prospective cohort, 1-3 monthsVery relevant and feasible if both procedures are routinely done
7. Prospective evaluation of post-mastectomy shoulder dysfunction and effect of early physiotherapyBefore-after or cohort design, 1-3 monthsSimple goniometry and validated functional questionnaire
8. Incidence of chronic post-mastectomy pain syndrome at 3 months and associated factorsCohort, 3-month follow-upClinically meaningful; use Numeric Rating Scale/DN4 questionnaire
9. Quality-of-life changes before and after breast cancer surgeryProspective cohort, baseline and 1-3 monthsUse EORTC QLQ-C30 with BR23/BR45, or BREAST-Q if locally accessible
10. Patient satisfaction with preoperative counselling and informed consent in breast cancer surgeryCross-sectional prospective survey before discharge or at 2 weeksVery easy, but less surgically academic than complication studies
11. Concordance of preoperative ultrasound axillary assessment with final histopathologyProspective diagnostic-accuracy studyRoutine imaging and pathology data only
12. Clinical and ultrasound predictors of residual nodal disease after neoadjuvant chemotherapyProspective cohortGood topic if your centre has adequate neoadjuvant cases
13. Accuracy of clinical and radiological assessment of response after neoadjuvant chemotherapy compared with final pathologyProspective observational studyRelevant but may need enough MRI/USG and pathology standardization
14. Predictors of positive margins after breast-conserving surgeryProspective cohortClear endpoint, but may require a larger sample
15. Short-term outcomes of breast-conserving surgery versus modified radical mastectomyComparative cohort, 30 days/3 monthsMeasure complications, pain, hospital stay, satisfaction
16. Factors influencing choice of mastectomy versus breast-conserving surgery among women with operable breast cancerProspective questionnaire-based cohortEasy recruitment; needs a carefully designed questionnaire
17. Nutritional status and postoperative wound complications after breast cancer surgeryCohort, 30 daysRecord BMI, albumin if routinely available, diabetes, wound events
18. Prevalence and predictors of anxiety before breast cancer surgeryProspective survey, preoperative and postoperative follow-upUse HADS or GAD-7; requires psychiatry/ethics input for referral pathway
19. Prospective audit of compliance with enhanced-recovery elements in breast surgery and early postoperative outcomesAudit/cohort, hospital stay plus 30 daysUseful if ERAS elements are already in practice
20. Effect of drain volume at removal on subsequent seroma formation after modified radical mastectomyProspective observational cohortVery practical, but do not alter your unit's usual drain-removal protocol solely for research

Best 5 topics if you want minimum difficulty

1. Postoperative seroma after modified radical mastectomy

Suggested title:
“Incidence and predictors of seroma formation following modified radical mastectomy for breast cancer: a prospective observational study.”
  • Data: age, BMI, diabetes, neoadjuvant therapy, breast size, nodal dissection, drain output, drain duration, seroma aspiration.
  • Follow-up: drain removal and 30 days.
  • Very feasible and likely good case numbers.

2. Early arm morbidity after axillary surgery

Suggested title:
“Prospective assessment of early upper-limb morbidity following sentinel lymph-node biopsy and axillary lymph-node dissection in breast cancer.”
  • Outcomes: pain, numbness, restricted shoulder abduction, arm swelling, seroma.
  • Follow-up: preoperative baseline, postoperative 1 month and 3 months.
  • More academically strong than a pure complication audit.

3. Post-mastectomy pain

Suggested title:
“Acute and chronic post-mastectomy pain: incidence, severity, and predictors in women undergoing surgery for breast cancer.”
  • Use NRS pain score and DN4 screening questionnaire.
  • Follow-up at discharge, 1 month, and 3 months.
  • Include age, type of surgery, axillary procedure, drain duration, chemotherapy, radiotherapy, and analgesic requirement.

4. Surgical-site infection

Suggested title:
“Incidence and risk factors for 30-day surgical-site infection after breast cancer surgery: a prospective cohort study.”
  • Straightforward definitions and a short follow-up.
  • Include diabetes, BMI, neoadjuvant chemotherapy, drain duration, operative time, and type of surgery.

5. Drain duration and output

Suggested title:
“Predictors of prolonged drainage after modified radical mastectomy for breast cancer: a prospective observational study.”
  • One of the simplest possible surgical topics.
  • May be less novel, so frame it around developing a locally applicable prediction model or identifying modifiable factors.

My recommendation

Choose this if your unit performs many MRM procedures:
“Incidence and predictors of seroma formation following modified radical mastectomy for breast cancer: a prospective observational study.”
It has the best balance of:
  • Easy recruitment
  • Low cost
  • Short follow-up
  • Simple endpoints
  • No extra imaging or expensive tests
  • Direct relevance to breast surgery practice
For a slightly stronger academic topic, choose:
“Prospective assessment of early upper-limb morbidity following sentinel lymph-node biopsy and axillary lymph-node dissection in breast cancer.”
Current breast surgical research is increasingly focused on limiting axillary treatment-related morbidity without compromising oncological safety. Patient-reported outcomes are also recognized as an important measure of success after breast surgery, beyond conventional complication rates. Recent breast surgery proceedings continue to report seroma, infection, hematoma, drain duration, and arm morbidity as relevant short-term outcomes (ASBrS proceedings).

Basic prospective protocol format

  • Study design: Prospective observational cohort study
  • Study population: Consecutive operable breast cancer patients undergoing surgery
  • Sample size: Usually based on expected incidence of the primary outcome, with allowance for loss to follow-up
  • Primary outcome: Choose one only, for example seroma at 30 days
  • Secondary outcomes: Drain duration, SSI, wound dehiscence, pain, hospital stay, reintervention
  • Follow-up: Discharge, drain removal, postoperative day 14, and day 30
  • Analysis: Incidence plus univariable and multivariable analysis of predictors
Do not use a non-validated, self-made questionnaire for pain, quality of life, anxiety, or arm function if a validated tool is available.
This is a shared conversation. Sign in to Orris to start your own chat.